BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
3.690
+0.075 (2.07%)
At close: May 22, 2026, 4:00 PM EDT
3.750
+0.060 (1.63%)
After-hours: May 22, 2026, 4:32 PM EDT
BioAtla Stock Forecast
BCAB's stock price has decreased by -80.69% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for BioAtla stock has a target of $500, which predicts a 13,450.14% increase from the current stock price of 3.69.
Price Target: $500 (+13,450.14%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for BioAtla is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 13, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Maintains $250 → $50 | Buy | Maintains | $250 → $50 | +1,255.01% | Mar 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 13, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $250 | Buy | Reiterates | $250 | +6,675.07% | Sep 16, 2024 |
Financial Forecast
Revenue This Year
n/a
from 2.00M
Revenue Next Year
n/a
EPS This Year
-46.92
from -50.66
EPS Next Year
-1.19
from -46.92
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -48.30 | -1.23 | |
| Avg | -46.92 | -1.19 | |
| Low | -45.08 | -1.15 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.